UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6351
InfuSystem Holdings
INFU
$240M
| $75.9K | ﹤0.01% |
11,110
-11,699
| -51% | -$86K |
|
6352
Natural Gas Services Group
NGS
$476M
| $75.9K | ﹤0.01% |
3,770
+2,745
| +268% | +$60.3K |
|
6353
Sprott Physical Silver Trust
PSLV
$13.2B
| $75.8K | ﹤0.01% |
7,631
-434
| -5% | -$4.21K |
|
6354
Viemed Healthcare
VMD
$372M
| $75.7K | ﹤0.01% |
11,558
-25,885
| -69% | -$195K |
|
6355
Impact Shares NAACP Minority Empowerment ETF
NACP
$76.7M
| $75.6K | ﹤0.01% |
+1,915
| New | +$73.1K |
|
6356
Strawberry Fields REIT
STRW
$190M
| $75.6K | ﹤0.01% |
+6,627
| New | +$64.7K |
|
|
LEXXW
6357
DELISTED
Lexaria Bioscience Warrant
LEXXW
| $75.5K | ﹤0.01% |
93,722
+93,623
| +94,569% | +$106K |
|
6358
TransCode Therapeutics
RNAZ
$4.23M
| $75.3K | ﹤0.01% |
+81
| New | +$72.1K |
|
6359
BNY Mellon Emerging Markets Equity ETF
BKEM
$85.7M
| $75.2K | ﹤0.01% |
+3,771
| New | +$73.7K |
|
6360
Backblaze
BLZE
$1.14B
| $75.2K | ﹤0.01% |
12,201
+11,299
| +1,253% | +$88.1K |
|
6361
Cheetah Net Supply Chain Service
CTNT
$5.97M
| $75K | ﹤0.01% |
56
+55
| +5,500% | +$312K |
|
6362
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF
XHLF
$1.94B
| $75K | ﹤0.01% |
1,491
-4,231
| -74% | -$212K |
|
6363
JPMorgan Inflation Managed Bond ETF
JCPI
$870M
| $74.9K | ﹤0.01% |
1,605
-79
| -5% | -$3.67K |
|
6364
Annovis Bio
ANVS
$79.6M
| $74.8K | ﹤0.01% |
12,990
+12,390
| +2,065% | +$100K |
|
|
PAMT
6365
PAMT Corp
PAMT
$284M
| $74.7K | ﹤0.01% |
4,298
-3,085
| -42% | -$49.8K |
|
|
MSVX
6366
DELISTED
LHA Market State Alpha Seeker ETF
MSVX
| $74.5K | ﹤0.01% |
3,083
+2,988
| +3,145% | +$71.1K |
|
6367
American Outdoor Brands
AOUT
$160M
| $74.4K | ﹤0.01% |
8,269
-2,863
| -26% | -$23.8K |
|
|
ASRT
6368
DELISTED
Assertio
ASRT
| $74.2K | ﹤0.01% |
3,991
-2,889
| -42% | -$42.9K |
|
6369
TScan Therapeutics
TCRX
$51M
| $74K | ﹤0.01% |
12,645
+10,744
| +565% | +$84.6K |
|
6370
Hub Cyber Security
HUBC
$29.2M
| $73.9K | ﹤0.01% |
+1
| New | +$147K |
|
6371
ProShares UltraShort QQQ
QID
$249M
| $73.9K | ﹤0.01% |
1,927
+1,146
| +147% | +$50.6K |
|
6372
vTv Therapeutics
VTVT
$141M
| $73.8K | ﹤0.01% |
4,180
+2,723
| +187% | +$64.9K |
|
6373
Crawford & Co Class A
CRD.A
$651M
| $73.8K | ﹤0.01% |
8,537
-8,788
| -51% | -$81.5K |
|
|
BNKK
6374
Bonk Inc
BNKK
$8.16M
| $73.8K | ﹤0.01% |
1,817
+1,803
| +12,879% | +$94.6K |
|
6375
AerSale
ASLE
$274M
| $73.7K | ﹤0.01% |
10,656
-31,104
| -74% | -$223K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.